Vivos Therapeutics Inc (VVOS) financials · rev $17.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Vivos Therapeutics Inc (VVOS) rev $17.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $17.4M | $15.0M |
| Cost of Revenue | $6.90M | $6.01M |
| Gross Profit | $10.5M | $9.02M |
| Operating Income | -$19.9M | -$11.2M |
| Net Income | -$21.2M | -$11.1M |
| EPS (Diluted) | -$2.07 | -$2.22 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $25.2M | $15.3M |
| Current Assets | $4.38M | $7.47M |
| Cash & Equivalents | $2.03M | $6.26M |
| PP&E | $3.76M | $3.35M |
| Total Liabilities | $26.7M | $7.33M |
| Current Liabilities | $18.1M | $4.98M |
| Short-term Debt | $8.35M | N/A |
| Long-term Debt | $469.0K | N/A |
| Total Debt | $2.90M | $1.20M |
| Shareholders' Equity | -$1.49M | $7.95M |
| Retained Earnings | -$125.4M | -$104.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$15.3M | -$12.7M |
| CapEx | $2.34M | $568.0K |
| Investing Cash Flow | -$7.53M | -$568.0K |
| Financing Cash Flow | $18.6M | $17.9M |
| Net Change in Cash | -$4.23M | $4.62M |
| Free Cash Flow | -$17.6M | -$13.3M |
FAQ
What is VVOS P/E and revenue?
Vivos Therapeutics Inc (VVOS) rev $17.4M.
What is VVOS revenue?
Vivos Therapeutics Inc last cached revenue is $17.4M (FY2025).
Is VVOS profitable?
Vivos Therapeutics Inc last cached net income is -$21.2M (FY2025).
What are VVOS total assets?
Vivos Therapeutics Inc last cached total assets are $25.2M (FY2025).
What is VVOS free cash flow?
Vivos Therapeutics Inc last cached free cash flow is -$17.6M (FY2025).
Not investment advice. Cached statements, not a live tape.